Deferasirox bis salicylamide impurity
| Product Name | Deferasirox bis salicylamide impurity |
|---|---|
| Alternate Names | Deferasirox Impurities, Impurities of Deferasirox |
| CAT No. | CS-O-05581 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 441.52 g/mol |
| Mol. For. | C21H35N3O7 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Deferasirox |
| Purity | >98% |
| Smileys | O=C(N(CCC1)[C@@H]1C(O)=O)[C@H](CCCCN)N[C@H](C(O)=O)CCC2=CC=CC=C2.O.O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Deferasirox bis salicylamide is an impurity that is commonly found in Deferasirox, a medication used for the treatment of chronic iron overload due to blood transfusions. This impurity is formed during the manufacturing process and can potentially affect the effectiveness and safety of the medication.
Chemically, Deferasirox bis salicylamide is a derivative of salicylic acid and is classified as a chelating agent. It works by binding to excess iron in the body and facilitating its removal through urine or feces. However, the presence of this impurity can lead to adverse effects such as gastrointestinal disturbances, liver toxicity, and renal impairment.
To ensure the safety and efficacy of Deferasirox, it is important to monitor the levels of Deferasirox bis salicylamide impurity during the manufacturing process and in the final product. This can be done using various analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS).
In conclusion, Deferasirox bis salicylamide impurity is a potential concern in the production and use of Deferasirox medication. Proper monitoring and control of this impurity are crucial to ensure the safety and effectiveness of the medication for patients with chronic iron overload.
Get an Instant Quote
Related Compounds
Deferasirox Impurity 3 | Deferasirox Impurity F | Azobenzene-4,4'-dicarboxylic Acid | Deferasirox Impurity 4 | Deferasirox Impurity 22 | Deferasirox Phase 1 impurity | Deferasirox Diacyl Impurity | Deferasirox Salicyloyl Ester | Deferasirox Impurity D | Deferasirox Hydrazino Impurity | Deferasirox Impurity 9 | Deferasirox Isopropyl Ester | Deferasirox Impurity 3 | Deferasirox Ethyl Ester | Deferasirox Amide Impurity | Deferasirox Impurity 25 |